Three new assays for rituximab based on its immunological activity or antigenic properties: analyses of sera and plasmas of RTX-treated patients with chronic lymphocytic leukemia and other B cell lymphomas-Reference-Cited by-同舟云学术

Three new assays for rituximab based on its immunological activity or antigenic properties: analyses of sera and plasmas of RTX-treated patients with chronic lymphocytic leukemia and other B cell lymphomas

Published:2004-06 Issue:1-2 Volume:289 Page:97-109
ISSN:0022-1759
Container-title:Journal of Immunological Methods
language:en
Short-container-title:Journal of Immunological Methods

Author:

Beum Paul V,Kennedy Adam D,Taylor Ronald P

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference30 articles.

1. Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma;Berinstein;Ann. Oncol.,1998

2. Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity;Byrd;J. Clin. Oncol.,2001

3. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIa gene;Cartron;Blood,2002

4. Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets;Clynes;Nat. Med.,2000

5. Complement-mediated lysis by anti-CD20 mAb correlates with segregation into lipid “rafts”;Cragg;Blood,2003

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rituximab induced cytokine release with high serum IP-10 (CXCL10) concentrations is associated with infusion reactions;Leukemia Research;2023-06

2. Research Progress on Quantification Methods of Drug Concentration of Monoclonal Antibodies;Current Pharmaceutical Analysis;2022-09

3. Quantitation and Identification of Therapeutic Anti-CD22 Monoclonal Antibodies in a Cell-Based ELISA Method;Antibodies;2022-08-16

4. Patient parameters and response after administration of rituximab in pediatric mature B‐cell non‐Hodgkin lymphoma;Pediatric Blood & Cancer;2021-12-22

5. Modeling Pharmacokinetics and Pharmacodynamics of Therapeutic Antibodies: Progress, Challenges, and Future Directions;Pharmaceutics;2021-03-21